Parallax Volatility Advisers’s M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 MBAC.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding MBAC.WS
Parallax Volatility Advisers's MBAC.WS Position: Q4 2023 in Review
Parallax Volatility Advisers sold out of M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (MBAC.WS) in Q4 2023, closing a stake of 25,000 shares — an estimated $1.13K sold.
Parallax Volatility Advisers first reported a position in MBAC.WS in Q1 2022 and held it in 7 quarters. The position peaked at $47.6K in Q1 2023. 1 fund tracked by Wall St. Rank holds MBAC.WS as of Q4 2023.
- Parallax Volatility Advisers reported no remaining M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q4 2023 after selling out during the quarter.
- Parallax Volatility Advisers sold 25,000 M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q4 2023, an estimated $1.13K.
- Parallax Volatility Advisers first reported a position in M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q1 2022 and held it in 7 quarters.
- Parallax Volatility Advisers's M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $47.6K in Q1 2023.
- 1 fund tracked by Wall St. Rank held M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q4 2023.
Based on Parallax Volatility Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.